Decreasing Hunger and Increasing Satiety Many weight loss drugs of the past had questionable results, but semaglutide, tirzepatide, and orforglipron may be game changers for weight management
Common Wegovy side effects include: Upset stomach, nausea, and vomiting Diarrhea or constipation Stomach pain Headache Fatigue Dizziness Gas, bloating, or belching Hypoglycemia (low blood sugar) Heartburn Runny nose or sore throat Redness and irritation at the injection site Wegovy may cause the following serious side effects: Severe allergic reactions Pancreatitis (inflammation of the pancreas) Gallstones and gallbladder problems Kidney problems or kidney failure Changes in vision Increased heart rate Depression or suicidal thoughts Wegovy may cause thyroid tumors, including thyroid cancer, and should not be used by individuals with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
We want to have a better understanding of how these medications impact eye health in terms of either preventing the progression of an eye disease or worsening an existing condition

See if you qualify for our weight loss or diabetes monitoring programs Starting at $90 for a 4-week supply Compounded Semaglutide Injection 4-weeks of Semaglutide Injection (All Refills / All Dosages / Same Price) Starting at $140 for a 4-week supply Compounded Tirzepatide Injection 4-weeks of Tirzepatide Injection (All Refills / All Dosages / Same Price) Starting at $90 for a 4-week supply* GLP-1 Core Medication 4-weeks of GLP-1 Core medication (All Refills / All Dosages / Same Price) Starting at $140 for a 4-week supply* GLP-1 Advanced Medication 4-weeks of GLP-1 Advanced medication (All Refills / All Dosages / Same Price) $0 with Medicare for those who qualify Dexcom G7 Monitoring Continuous glucose monitoring with remote care from your MDWatch team $0 with Medicare for those who qualify FreeStyle Libre Monitoring Continuous glucose monitoring with remote care from your MDWatch team Prefer to talk to someone

Michelle Van Name, assistant professor of pediatric endocrinology at the Yale School of Medicine
The peptide stimulates the pancreas to release insulin only when blood glucose rises